1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Global Automation and Control System Market in the Pharmaceutical and Biotech Industry

Growth of Biosimilars and Generic Drugs Drives the ACS Market

This research service identifies the major challenges in the pharmaceutical and biotech industry and discusses the automation and control system (ACS) market drivers and restraints, along with key trends in the technology and distribution of the automation control systems. The research service is a global study covering North America, Europe, Asia Pacific and other key emerging regions. A comprehensive forecast is provided for the automation control system market, across the following product segments: PLC, DCS, HMI SCADA, APC, MES, ECQM, and EAM, for the pharmaceutical and biotech industry. In addition, a competitive landscape and strategic conclusions for the market have been included.

Executive Summary

• The automation and control system (ACS) market in the pharmaceutical and biotech industry is expected to grow at a CAGR of X percent to $X million in 2019.
• The generic drug market has fueled the growth of the pharmaceutical industry over the past few years and the biotechnology market is likely to have a large number of investments due to the expected blockbuster drugs. This scenario shows the vast investment potential for new pharmaceutical projects that is driving the ACS market.
• Regulation is a major consideration for automation as it ensures compliance with safety considerations and guidelines. Good Automated Manufacturing Practice (GAMP) guidelines from the International Society for Pharmaceutical Engineering (ISPE) and the U.S. Food and Drug Administration’s (FDA) CFR part regulations are fundamental to automation solution providers in the pharmaceutical industry.
• With the rise of contract manufacturing, North American and European companies will shift primarily to a research and development role, while manufacturing will be outsourced to emerging regions.
• The generic market will continue to expand as more patent expirations are expected to contribute to a CAGR of X percent for the ACS market in the pharmaceutical industry, while the ACS market in the biotech industry is expected to grow at a CAGR of X percent until 2019.
• Though programmable logic controllers (PLC) and distributed control systems (DCS) contribute more than Xpercent of the market, the advanced process control (APC), manufacturing execution systems (MES), and enterprise compliance quality management (ECQM) segments show the highest CAGRs of X percent to Xpercent until 2019. The need for access to real-time data to make timely decisions drives these segments for process optimization.
• A steady trend in the shift from batch manufacturing to continuous manufacturing is seen in the pharmaceutical and biotech industry, as it requires flexible automation and control systems in incorporating this change. Single-use technology in manufacturing is another evolving industry dynamic.

CEO’s Perspective

1. Pharmaceutical manufacturers are looking for end-to-end solutions from providers so it is important to have the right alliances and partnerships.
2. End users require industry-specific standardized solutions for cost containment, so a good understanding of the industry adds value for the customers.
3. Contract manufacturing in emerging regions will boost the ACS market as the generic drug market continues to increase.
4. Quality management has gained importance among the pharmaceutical manufacturers that are integrating the base automation layer into ERP.
5. FDA’s initiatives and the industry’s changing attitude have made PAT a hot topic in the life science industry.

Geographic Regions Covered

North America—United states, Canada
EIA—Europe, Israel, Africa
APAC—India, China, Japan, South Korea, South East Asia, Australia, New Zealand
Others—Latin America, Russia, Middle East

Key Questions This Study Will Answer

• Is the automation and control system market growing in pharmaceutical and biotech, how long will it continue to grow, and at what rate?
• What are the key factors that will drive the growth of the automation and control system market in pharmaceuticals and biotech?
• What are the restraints faced by the market participants? What is the expected impact?
• What are the top requirements customers in pharmaceuticals and biotech are looking for in automation solutions?
• Who are the major industry participants? What is their relative position in the global automation and control system market?
• What are the future trends expected in the automation and control system market for pharmaceutical and biotech end-users?

Table Of Contents

Global Automation and Control System Market in the Pharmaceutical and Biotech Industry
Table of Contents

1. Executive Summary
2. Market Overview
3. Total ACS Market in Pharmaceutical and Biotech Industry
• External Challenges: Drivers and Restraints
• Forecasts and Trends
• Market Share and Competitive Analysis
• Mega Trends and Industry Convergence Implications
4. CEO's 360 Degree Perspective
5. PLC Segment Breakdown
6. DCS Segment Breakdown
7. HMI SCADA Segment Breakdown
8. APC Segment Breakdown
9. MES Segment Breakdown
10. ECQM Segment Breakdown
11. EAM Segment Breakdown
12. The Last Word
13. Appendix

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Poultry Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • September 2016
  • by Transparency Market Research

This report on the poultry pharmaceuticals market studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in ...


ref:plp2013

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.